Hafsa Akram, MD

Percutaneous Coronary Intervention and the Management of Acute Coronary Syndromes in Patients With von Willebrand Disease

04/01/2013

David C. Sane , MD;

Sulaiman Rathore , MD;

Dexter Deleon , MD;

Hafsa Akram , MD;

Tim Ball , MD, PhD;

The optimal management of patients with Von Willebrand disease and acute coronary syndrome is complex and presents a therapeutic challenge. We propose that dual-antiplatelet therapy can be used safely in most vWD patients presenting with ACS,...

The optimal management of...

04/01/2013

Journal of Invasive Cardiology

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 6 ⁠–⁠ November 8

November 7 ⁠–⁠ November 10

November 8

November 8 ⁠–⁠ November 10

November 13 ⁠–⁠ November 16

November 14 ⁠–⁠ November 15

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

See Full Calendar

Hafsa Akram, MD

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products